How can we expand active surveillance criteria in patients with low- and intermediate risk prostate cancer without increasing the risk of misclassification: Development of a novel risk calculator
暂无分享,去创建一个
F. Montorsi | L. Salomon | M. Graefen | N. Fossati | G. Gandaglia | A. Briganti | P. Sooriakumaran | I. Tsaur | A. Taille | A. Kretschmer | P. Ost | D. Tilki | C. Surcel | M. Valerio | G. Ploussard | R. Bergh | H. V. D. Poel